| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 06/18/2008 | EP1932426A1 Gene delivery system and methods of use |
| 06/18/2008 | EP1931762A1 Use of recombinant yeast strain producing an anti -inflammatory compound in the manufacture of a medicament to treat colitis |
| 06/18/2008 | EP1931694A1 Aptamers comprising arabinose modified nucleotides |
| 06/18/2008 | EP1198479B1 Neovascular-targeted immunoconjugates |
| 06/18/2008 | EP1115879B1 Retroviral particles protected against complement mediated destruction |
| 06/18/2008 | EP0840617B1 Use of naip or iap for the treatment and prevention of neuronal disease |
| 06/18/2008 | CN101203613A Method of increasing the function of gland related viral vector |
| 06/18/2008 | CN101200768A Application of MR-1 in tumor diagnosis and treatment as tumor marker and target molecule |
| 06/18/2008 | CN101200732A Hypoxia response elements gene treating plasmid and its constructing method |
| 06/18/2008 | CN101200721A Human myocardium protecting gene and uses thereof |
| 06/18/2008 | CN101200719A Liver cancer related gene DLK1 and uses thereof |
| 06/18/2008 | CN101200483A Antisense nucleic acid of resistant and tolerant dimethoxyphenecillin staphylococcus aureus drug resistant gene |
| 06/18/2008 | CN101200482A shRNA accelerating carcinoma cell apoptosis and uses thereof |
| 06/18/2008 | CN101199862A B7-1, CD40L mass particle mixture |
| 06/18/2008 | CN101199861A DNA vaccine for anti-liver cancer |
| 06/18/2008 | CN101199860A Cancer suppressing agent |
| 06/18/2008 | CN101199859A Inhibition lung cancer transfer and lung transfer tumor gene medicament |
| 06/18/2008 | CN101199858A Multiple target point small interference RNA cocktail agent for treating ophthalmic disease and preparing method thereof |
| 06/18/2008 | CN101199853A Bloodvesselofbrain endodermis cell target polylactic acid nanometer particle carrier, producing method and application thereof |
| 06/18/2008 | CN101199852A Polyethyleneimine of non-iron surfactant modifying, preparing and application |
| 06/18/2008 | CN100395335C siRNA double-chain for suppressing bc1-2 gene expression |
| 06/18/2008 | CN100395334C siRNA double-chain for suppressing bc1-2 gene expression |
| 06/18/2008 | CN100394984C Bivalent DNA vaccine for Japanese blood fluke and preparation process thereof |
| 06/18/2008 | CA2571348A1 Anti-tumour immunity and specific t cell memory are induced by low dose inoculation with nonreplicating recombinant adenovirus encoding tap1 |
| 06/17/2008 | US7388086 NPHS2 gene involved in the steroid-resistant nephrotic syndrome, protein encoded by said gene and diagnostic and therapeutic uses |
| 06/17/2008 | US7388078 Nucleic acids encoding polypeptides having chips activity |
| 06/17/2008 | US7387777 Methods of treating hemophilia or von willebrand disease with p-selectin |
| 06/17/2008 | US7387645 Cellular therapy to heal vascular tissue |
| 06/17/2008 | CA2247336C Parapoxviruses containing foreign dna, their production and their use in vaccines |
| 06/17/2008 | CA2187162C Dna encoding precursor of interleukin-1.beta. converting enzyme-related cysteine proteinase iii (icerel iii) |
| 06/12/2008 | WO2008070765A2 Light-sensitive constructs for inducing cell death and cell signaling |
| 06/12/2008 | WO2008070616A2 METHODS AND COMPOSITIONS RELATED TO HIF-1α |
| 06/12/2008 | WO2008070477A2 Polymeric short interfering rna conjugates |
| 06/12/2008 | WO2008070363A2 Intrabodies |
| 06/12/2008 | WO2008070273A2 Methods of expressing lim mineralization protein |
| 06/12/2008 | WO2008070082A2 Stem-progenitor cell specific micro-ribonucleic acids and uses thereof |
| 06/12/2008 | WO2008069890A2 Adrenal grk2 activity as a therapeutic target for heart failure |
| 06/12/2008 | WO2008069517A1 Composition and method for inhibition of lipogenesis by suppressing the expression of protein kinase c delta binding protein |
| 06/12/2008 | WO2008068982A1 Adjuvant for gene transfer comprising cell migration peptide as the active ingredient and gene transfer method using the adjuvant for gene transfer |
| 06/12/2008 | WO2008068945A1 Gene transfer aid comprising peptide capable of migrating into cell as active ingredient, and gene transfer method utilizing the gene transfer aid |
| 06/12/2008 | WO2008068827A1 Kidney-specific novel organic ion transporter |
| 06/12/2008 | WO2008031854A3 Nucleic acids for expressing a polynucleotide of interest in mammalian cancer cells |
| 06/12/2008 | WO2008026223A3 An aqueous formulation for selective targeting and delivering gene to cancer cells |
| 06/12/2008 | WO2007132338A3 IL-1α IMMUNIZATION INDUCES AUTOANTIBODIES PROTECTIVE AGAINST ATHEROSCLEROSIS |
| 06/12/2008 | WO2007107304A3 An efficient method for loading amphoteric liposomes with nucleic acid active substances |
| 06/12/2008 | WO2007005879A3 Compositions and methods for the treatment or prevention of disorders relating to oxidative stress |
| 06/12/2008 | WO2005046434A8 Compositions and methods for diagnosing and treating mental disorders |
| 06/12/2008 | US20080141386 Chromosomal Loci For The Stringent Control Of Gene Activities Via Transcription Activation Systems |
| 06/12/2008 | US20080139798 siRNA targeting myeloid cell leukemia sequence 1 |
| 06/12/2008 | US20080139494 Introducing genetic material topically or by lavage into mucosal tissue cells of an individual, including rectal, vaginal, urethral, sublingual and buccal; used to deliver genetic material that encodes protein targets for immunization against pathogen infection, hyperproliferative or autoimmune diseases |
| 06/12/2008 | US20080139477 Introduced DNA sequences are replicated, stably retained and segregated independent of continuous selection pressure |
| 06/12/2008 | US20080139476 Caspase-8 interacting proteins |
| 06/12/2008 | US20080138901 Nucleotide having encapsidation signal and lacking overlapping sequences with nucleic acid of cell; safe large scale production; replication-defective |
| 06/12/2008 | US20080138877 Device which utilizes electrical pulse to make membranes porous to bioactive agents; drug delivery; gene therapy |
| 06/12/2008 | US20080138337 Connexin enhances chemotherapy-induced apoptosis in human cancer cells inhibiting tumor cell proliferation |
| 06/12/2008 | US20080138331 Using uterine tumor specific marker as diagnostic tool in detection of urogenital specific cell proliferative disorders |
| 06/12/2008 | US20080138325 Using microprojectiles comprising immobilized polynucleotide sequences as gene transfer agents |
| 06/12/2008 | US20080138322 Pretreating with lipophilic substituted saccharide |
| 06/12/2008 | US20080138319 Stem cell tissue for use in treatment of nervous system disorders; tissue engineering; regenerative medicine |
| 06/12/2008 | US20080138318 Compositions Comprising Viruses and Methods for Concentrating Virus Preparations |
| 06/12/2008 | US20080138314 Use of il-22 for the treatment of conditions of metabolic disorders |
| 06/12/2008 | CA2671492A1 Compositions and methods to treat cancer with cupredoxins and cpg rich dna |
| 06/11/2008 | EP1930728A1 Use of the mal protein as a tumour marker |
| 06/11/2008 | EP1930439A1 Neurotrophic factors |
| 06/11/2008 | EP1930436A1 Vector for delivering target substance into nucleus or cell |
| 06/11/2008 | EP1930433A1 T-cell receptor and nucleic acid encoding the receptor |
| 06/11/2008 | EP1930420A1 Isolated nucleic acid molecules encoding a bacterial uracil phosphoribosyl-transferase enzyme, cells transformed therewith and uses thereof |
| 06/11/2008 | EP1930340A1 Antiproliferative activity of G-rich oligonucleotides and method of using the same to bind to nucleolin |
| 06/11/2008 | EP1930022A1 Treatment of bladder fibrosis with antibodies against alpha V beta 6 integrin |
| 06/11/2008 | EP1928504A1 Liver-directed gene therapy |
| 06/11/2008 | EP1758612B1 Composition comprising intercalated functional-active organic compounds |
| 06/11/2008 | EP1558737A4 Gene families associated with cancers |
| 06/11/2008 | EP1420769B1 Lipid profile modulation with steroids and ppar alpha agonists |
| 06/11/2008 | EP1391511B1 Artificial human chromosome containing human antibody lambda light chain gene |
| 06/11/2008 | EP1372621B1 Novel use of tyrosine kinase frk inhibitor |
| 06/11/2008 | EP1282436B1 Treatment of acute coronary syndrome with glp-1 |
| 06/11/2008 | EP1165113B1 USE OF ErbB RECEPTOR LIGANDS IN TREATING DIABETES |
| 06/11/2008 | EP0979298B1 Metastasis models using green fluorescent protein (gfp) as a marker |
| 06/11/2008 | EP0948522B1 Therapeutic and diagnostic agents capable of modulating cellular responsiveness to cytokines |
| 06/11/2008 | CN101198358A Recombinant BCG strains with enhanced ability to escape the endosome |
| 06/11/2008 | CN101195831A Dual-purpose vaccine carrier for foot and mouth disease virus, production method and application of the same |
| 06/11/2008 | CN101195826A Patina pseudomonas biological tunica forming correlation gene film and application of the same |
| 06/11/2008 | CN101195657A Type I cell factor receptor sample molecule, encoding gene and application thereof |
| 06/11/2008 | CN100393356C Modified cytokines for use in cancer therapy |
| 06/11/2008 | CN100393209C Modified oligonucleotides for telomerase inhibition |
| 06/10/2008 | USRE40374 immunomodulators comprising interleukins, Flt-3 ligands, CD antigens, interferons, colony stimulating factors, nucleotides and proteins coded by such nucleotides, antibodies raised against such proteins, used to elicit immune responses in mammals |
| 06/10/2008 | US7385045 Naturally-occurring variants of B7 proteins produced by alternative RNA splicing or alternative termination of full-length amino acid sequence; regulation of immune response in an animal; immunostimulants; anticarcinogenic agents, infections; antiallergens; antiinflammatory agents; veterinary medicine |
| 06/10/2008 | US7385026 Modified ghrelin polypeptides |
| 06/10/2008 | US7384784 Pax-encoding vector and use thereof |
| 06/10/2008 | US7384775 Comprises nucleotide sequences coding surface localized streptococcal polypeptides for design of vaccines for prevention of non-systemic diseases such as otitis media; genetic vaccines |
| 06/10/2008 | US7384774 entirely vector-based intracellular system; introducing into a 293T cell expression vectors capable of expressing genomic or antigenomic vRNA segments, and a nucleoprotein, and an RNA-dependent polymerase |
| 06/10/2008 | US7384644 Modified Vaccinia Ankara virus variant |
| 06/10/2008 | US7384643 genetically engineered to be incapable of expressing a native A41L protein; binds to chemokines in the CXC group. |
| 06/10/2008 | US7384632 for prevention and/or treatment of cellular degeneration, including nerve cell damage associated with acute nervous cell system injury and chronic neurodegenerative diseases, including peripheral neuropathy |
| 06/10/2008 | CA2358040C Use of the cell's own transport system for transferring nucleic acids across the nuclear membrane |
| 06/10/2008 | CA2191750C Virosome-mediated intracellular delivery of therapeutic agents |
| 06/10/2008 | CA2153756C Transport protein which effects the transport of cationic xenobiotics and/or pharmaceuticals, dna sequences encoding it and their use |
| 06/05/2008 | WO2008067382A2 Rnai-mediated inhibition of aquaporin 4 for treatment of iop-related conditions |
| 06/05/2008 | WO2008067373A2 RNAi-MEDIATED INHIBITION OF AQUAPORIN 1 FOR TREATMENT OF IOP-RELATED CONDITIONS |
| 06/05/2008 | WO2008067180A2 Centrosomal proteins and secretion |